APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Dutasteride Drug

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Dutasteride Drug Market Outlook and Growth Opportunities 2026

Report ID 173987060429 December 2025205 pages

Choose your research edition.

Industry ResearchDutasteride Drug Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Dutasteride Drug Industry Growth and Trends Forecast to 2032116 pages · $3,450 USDMarket StructureGlobal Dutasteride Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dutasteride Drug Market Outlook and Growth Opportunities 2026205 pages · $4,250 USDMarket Analysis & ForecastGlobal Dutasteride Drug Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

The global Dutasteride Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Dutasteride Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Dutasteride Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Dutasteride Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Dutasteride Drug market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Dutasteride Drug market include GSK, Acella Pharmaceuticals, Amneal Pharmaceuticals, Ascent Pharmaceuticals, Aurobindo Pharma, Barr Pharmaceuticals, Chartwell, Endo and Strides Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Dutasteride Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Dutasteride Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Dutasteride Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Dutasteride Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Dutasteride Drug Segment by Company

GSK

Acella Pharmaceuticals

Amneal Pharmaceuticals

Ascent Pharmaceuticals

Aurobindo Pharma

Barr Pharmaceuticals

Chartwell

Endo

Strides Pharma

Waylis Therapeutics

Zydus

Chengdu Suncadia Medicine

Jiangsu Wangao Pharmaceutical

Qilu Pharmaceutical

Humanwell Puracap

Sichuan Gowell Pharmaceutical

Dutasteride Drug Segment by Type

Single Drug

Combination Preparation

Dutasteride Drug Segment by Application

Retail Pharmacy

Hospital Pharmacy

Online Pharmacy

Dutasteride Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Dutasteride Drug status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Dutasteride Drug market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Dutasteride Drug significant trends, drivers, influence factors in global and regions.

6. To analyze Dutasteride Drug competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dutasteride Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dutasteride Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dutasteride Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Dutasteride Drug market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Dutasteride Drug industry.

Chapter 3: Detailed analysis of Dutasteride Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Dutasteride Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Dutasteride Drug in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Dutasteride Drug Industry Trends Table 2. Dutasteride Drug Industry Drivers Table 3. Dutasteride Drug Industry Opportunities and Challenges Table 4. Dutasteride Drug Industry Restraints Table 5. Global Dutasteride Drug Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Dutasteride Drug Revenue Share by Company (2021-2026) Table 7. Global Dutasteride Drug Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Dutasteride Drug Sales Volume Share by Company (2021-2026) Table 9. Global Dutasteride Drug Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Dutasteride Drug Company Ranking, (2024-2026) & (USD Million) Table 11. Global Dutasteride Drug Key Company Manufacturing Base & Headquarters Table 12. Global Dutasteride Drug Company, Product Type & Application Table 13. Global Dutasteride Drug Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Dutasteride Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Single Drug Table 18. Significant Companies of Combination Preparation Table 19. Global Dutasteride Drug Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Dutasteride Drug Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Dutasteride Drug Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Dutasteride Drug Sales Volume Share by Type (2021-2026) Table 23. Global Dutasteride Drug Sales Volume Share by Type (2027-2032) Table 24. Global Dutasteride Drug Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Dutasteride Drug Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Dutasteride Drug Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Dutasteride Drug Sales Value Share by Type (2021-2026) Table 28. Global Dutasteride Drug Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Retail Pharmacy Table 30. Significant Companies of Hospital Pharmacy Table 31. Significant Companies of Online Pharmacy Table 32. Global Dutasteride Drug Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Dutasteride Drug Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Dutasteride Drug Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Dutasteride Drug Sales Volume Share by Application (2021-2026) Table 36. Global Dutasteride Drug Sales Volume Share by Application (2027-2032) Table 37. Global Dutasteride Drug Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Dutasteride Drug Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Dutasteride Drug Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Dutasteride Drug Sales Value Share by Application (2021-2026) Table 41. Global Dutasteride Drug Sales Value Share by Application (2027-2032) Table 42. Global Dutasteride Drug Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Dutasteride Drug Sales by Region (2021-2026) & (K Units) Table 44. Global Dutasteride Drug Sales Market Share by Region (2021-2026) Table 45. Global Dutasteride Drug Sales by Region (2027-2032) & (K Units) Table 46. Global Dutasteride Drug Sales Market Share by Region (2027-2032) Table 47. Global Dutasteride Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Dutasteride Drug Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Dutasteride Drug Sales Value Share by Region (2021-2026) Table 50. Global Dutasteride Drug Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Dutasteride Drug Sales Value Share by Region (2027-2032) Table 52. Global Dutasteride Drug Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Dutasteride Drug Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Dutasteride Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Dutasteride Drug Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Dutasteride Drug Sales by Country (2021-2026) & (K Units) Table 57. Global Dutasteride Drug Sales Market Share by Country (2021-2026) Table 58. Global Dutasteride Drug Sales by Country (2027-2032) & (K Units) Table 59. Global Dutasteride Drug Sales Market Share by Country (2027-2032) Table 60. Global Dutasteride Drug Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Dutasteride Drug Sales Value Market Share by Country (2021-2026) Table 62. Global Dutasteride Drug Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Dutasteride Drug Sales Value Market Share by Country (2027-2032) Table 64. GSK Company Information Table 65. GSK Business Overview Table 66. GSK Dutasteride Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. GSK Dutasteride Drug Product Portfolio Table 68. GSK Recent Development Table 69. Acella Pharmaceuticals Company Information Table 70. Acella Pharmaceuticals Business Overview Table 71. Acella Pharmaceuticals Dutasteride Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Acella Pharmaceuticals Dutasteride Drug Product Portfolio Table 73. Acella Pharmaceuticals Recent Development Table 74. Amneal Pharmaceuticals Company Information Table 75. Amneal Pharmaceuticals Business Overview Table 76. Amneal Pharmaceuticals Dutasteride Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Amneal Pharmaceuticals Dutasteride Drug Product Portfolio Table 78. Amneal Pharmaceuticals Recent Development Table 79. Ascent Pharmaceuticals Company Information Table 80. Ascent Pharmaceuticals Business Overview Table 81. Ascent Pharmaceuticals Dutasteride Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Ascent Pharmaceuticals Dutasteride Drug Product Portfolio Table 83. Ascent Pharmaceuticals Recent Development Table 84. Aurobindo Pharma Company Information Table 85. Aurobindo Pharma Business Overview Table 86. Aurobindo Pharma Dutasteride Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Aurobindo Pharma Dutasteride Drug Product Portfolio Table 88. Aurobindo Pharma Recent Development Table 89. Barr Pharmaceuticals Company Information Table 90. Barr Pharmaceuticals Business Overview Table 91. Barr Pharmaceuticals Dutasteride Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Barr Pharmaceuticals Dutasteride Drug Product Portfolio Table 93. Barr Pharmaceuticals Recent Development Table 94. Chartwell Company Information Table 95. Chartwell Business Overview Table 96. Chartwell Dutasteride Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Chartwell Dutasteride Drug Product Portfolio Table 98. Chartwell Recent Development Table 99. Endo Company Information Table 100. Endo Business Overview Table 101. Endo Dutasteride Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Endo Dutasteride Drug Product Portfolio Table 103. Endo Recent Development Table 104. Strides Pharma Company Information Table 105. Strides Pharma Business Overview Table 106. Strides Pharma Dutasteride Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Strides Pharma Dutasteride Drug Product Portfolio Table 108. Strides Pharma Recent Development Table 109. Waylis Therapeutics Company Information Table 110. Waylis Therapeutics Business Overview Table 111. Waylis Therapeutics Dutasteride Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Waylis Therapeutics Dutasteride Drug Product Portfolio Table 113. Waylis Therapeutics Recent Development Table 114. Zydus Company Information Table 115. Zydus Business Overview Table 116. Zydus Dutasteride Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Zydus Dutasteride Drug Product Portfolio Table 118. Zydus Recent Development Table 119. Chengdu Suncadia Medicine Company Information Table 120. Chengdu Suncadia Medicine Business Overview Table 121. Chengdu Suncadia Medicine Dutasteride Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Chengdu Suncadia Medicine Dutasteride Drug Product Portfolio Table 123. Chengdu Suncadia Medicine Recent Development Table 124. Jiangsu Wangao Pharmaceutical Company Information Table 125. Jiangsu Wangao Pharmaceutical Business Overview Table 126. Jiangsu Wangao Pharmaceutical Dutasteride Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Jiangsu Wangao Pharmaceutical Dutasteride Drug Product Portfolio Table 128. Jiangsu Wangao Pharmaceutical Recent Development Table 129. Qilu Pharmaceutical Company Information Table 130. Qilu Pharmaceutical Business Overview Table 131. Qilu Pharmaceutical Dutasteride Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. Qilu Pharmaceutical Dutasteride Drug Product Portfolio Table 133. Qilu Pharmaceutical Recent Development Table 134. Humanwell Puracap Company Information Table 135. Humanwell Puracap Business Overview Table 136. Humanwell Puracap Dutasteride Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. Humanwell Puracap Dutasteride Drug Product Portfolio Table 138. Humanwell Puracap Recent Development Table 139. Sichuan Gowell Pharmaceutical Company Information Table 140. Sichuan Gowell Pharmaceutical Business Overview Table 141. Sichuan Gowell Pharmaceutical Dutasteride Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 142. Sichuan Gowell Pharmaceutical Dutasteride Drug Product Portfolio Table 143. Sichuan Gowell Pharmaceutical Recent Development Table 144. Key Raw Materials Table 145. Raw Materials Key Suppliers Table 146. Dutasteride Drug Distributors List Table 147. Dutasteride Drug Customers List Table 148. Research Programs/Design for This Report Table 149. Authors List of This Report Table 150. Secondary Sources Table 151. Primary Sources List of Figures Figure 1. Dutasteride Drug Product Image Figure 2. Global Dutasteride Drug Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Dutasteride Drug Sales Value (2021-2032) & (US$ Million) Figure 4. Global Dutasteride Drug Sales (2021-2032) & (K Units) Figure 5. Global Dutasteride Drug Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Dutasteride Drug Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Single Drug Image Figure 10. Combination Preparation Image Figure 11. Global Dutasteride Drug Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Dutasteride Drug Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Dutasteride Drug Sales Volume Share by Type (2021-2032) Figure 14. Global Dutasteride Drug Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Dutasteride Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Dutasteride Drug Sales Value Share by Type (2021-2032) Figure 17. Retail Pharmacy Image Figure 18. Hospital Pharmacy Image Figure 19. Online Pharmacy Image Figure 20. Global Dutasteride Drug Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Dutasteride Drug Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Dutasteride Drug Sales Volume Share by Application (2021-2032) Figure 23. Global Dutasteride Drug Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Dutasteride Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Dutasteride Drug Sales Value Share by Application (2021-2032) Figure 26. Global Dutasteride Drug Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Dutasteride Drug Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Dutasteride Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Dutasteride Drug Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Dutasteride Drug Sales Value (2021-2032) & (US$ Million) Figure 31. North America Dutasteride Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Dutasteride Drug Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Dutasteride Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Dutasteride Drug Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Dutasteride Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Dutasteride Drug Sales Value (2021-2032) & (US$ Million) Figure 37. South America Dutasteride Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Dutasteride Drug Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Dutasteride Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Dutasteride Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Dutasteride Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Dutasteride Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Dutasteride Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Dutasteride Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Dutasteride Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Dutasteride Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Dutasteride Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Dutasteride Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Dutasteride Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Dutasteride Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Dutasteride Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Dutasteride Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Dutasteride Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Dutasteride Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Dutasteride Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Dutasteride Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Dutasteride Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Dutasteride Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Dutasteride Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Dutasteride Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Dutasteride Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Dutasteride Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Dutasteride Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Dutasteride Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Dutasteride Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Dutasteride Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Dutasteride Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Dutasteride Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Dutasteride Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Dutasteride Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Dutasteride Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Dutasteride Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Dutasteride Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Dutasteride Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Dutasteride Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Dutasteride Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Dutasteride Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Dutasteride Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Dutasteride Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Dutasteride Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Dutasteride Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Dutasteride Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Dutasteride Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Dutasteride Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Dutasteride Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Dutasteride Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Dutasteride Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Dutasteride Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Dutasteride Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Dutasteride Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Dutasteride Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Dutasteride Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Dutasteride Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Dutasteride Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Dutasteride Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Dutasteride Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Dutasteride Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Dutasteride Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Dutasteride Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Dutasteride Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Dutasteride Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Dutasteride Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Dutasteride Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Dutasteride Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Dutasteride Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Dutasteride Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Dutasteride Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Dutasteride Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Dutasteride Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Dutasteride Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Dutasteride Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Dutasteride Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Dutasteride Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Dutasteride Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Dutasteride Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Dutasteride Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Dutasteride Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Dutasteride Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Dutasteride Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Dutasteride Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Dutasteride Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Dutasteride Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Dutasteride Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Dutasteride Drug Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Dutasteride Drug Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Single Drug
  • Combination Preparation
Applications
  • Retail Pharmacy
  • Hospital Pharmacy
  • Online Pharmacy
Companies covered
  • GSK
  • Acella Pharmaceuticals
  • Amneal Pharmaceuticals
  • Ascent Pharmaceuticals
  • Aurobindo Pharma
  • Barr Pharmaceuticals
  • Chartwell
  • Endo
  • Strides Pharma
  • Waylis Therapeutics
  • Zydus
  • Chengdu Suncadia Medicine
  • Jiangsu Wangao Pharmaceutical
  • Qilu Pharmaceutical
  • Humanwell Puracap
  • Sichuan Gowell Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Dutasteride Drug Sales Value (2021-2032)
  4. 1.2.2 Global Dutasteride Drug Sales Volume (2021-2032)
  5. 1.2.3 Global Dutasteride Drug Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Dutasteride Drug Market Dynamics
  1. 2.1 Dutasteride Drug Industry Trends
  2. 2.2 Dutasteride Drug Industry Drivers
  3. 2.3 Dutasteride Drug Industry Opportunities and Challenges
  4. 2.4 Dutasteride Drug Industry Restraints
3 Dutasteride Drug Market by Company
  1. 3.1 Global Dutasteride Drug Company Revenue Ranking in 2025
  2. 3.2 Global Dutasteride Drug Revenue by Company (2021-2026)
  3. 3.3 Global Dutasteride Drug Sales Volume by Company (2021-2026)
  4. 3.4 Global Dutasteride Drug Average Price by Company (2021-2026)
  5. 3.5 Global Dutasteride Drug Company Ranking (2024-2026)
  6. 3.6 Global Dutasteride Drug Company Manufacturing Base and Headquarters
  7. 3.7 Global Dutasteride Drug Company Product Type and Application
  8. 3.8 Global Dutasteride Drug Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Dutasteride Drug Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Dutasteride Drug Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Dutasteride Drug Market by Type
  1. 4.1 Dutasteride Drug Type Introduction
  2. 4.1.1 Single Drug
  3. 4.1.2 Combination Preparation
  4. 4.2 Global Dutasteride Drug Sales Volume by Type
  5. 4.2.1 Global Dutasteride Drug Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Dutasteride Drug Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Dutasteride Drug Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Dutasteride Drug Sales Value by Type
  9. 4.3.1 Global Dutasteride Drug Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Dutasteride Drug Sales Value by Type (2021-2032)
  11. 4.3.3 Global Dutasteride Drug Sales Value Share by Type (2021-2032)
5 Dutasteride Drug Market by Application
  1. 5.1 Dutasteride Drug Application Introduction
  2. 5.1.1 Retail Pharmacy
  3. 5.1.2 Hospital Pharmacy
  4. 5.1.3 Online Pharmacy
  5. 5.2 Global Dutasteride Drug Sales Volume by Application
  6. 5.2.1 Global Dutasteride Drug Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Dutasteride Drug Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Dutasteride Drug Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Dutasteride Drug Sales Value by Application
  10. 5.3.1 Global Dutasteride Drug Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Dutasteride Drug Sales Value by Application (2021-2032)
  12. 5.3.3 Global Dutasteride Drug Sales Value Share by Application (2021-2032)
6 Dutasteride Drug Regional Sales and Value Analysis
  1. 6.1 Global Dutasteride Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Dutasteride Drug Sales by Region (2021-2032)
  3. 6.2.1 Global Dutasteride Drug Sales by Region: 2021-2026
  4. 6.2.2 Global Dutasteride Drug Sales by Region (2027-2032)
  5. 6.3 Global Dutasteride Drug Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Dutasteride Drug Sales Value by Region (2021-2032)
  7. 6.4.1 Global Dutasteride Drug Sales Value by Region: 2021-2026
  8. 6.4.2 Global Dutasteride Drug Sales Value by Region (2027-2032)
  9. 6.5 Global Dutasteride Drug Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Dutasteride Drug Sales Value (2021-2032)
  12. 6.6.2 North America Dutasteride Drug Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Dutasteride Drug Sales Value (2021-2032)
  15. 6.7.2 Europe Dutasteride Drug Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Dutasteride Drug Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Dutasteride Drug Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Dutasteride Drug Sales Value (2021-2032)
  21. 6.9.2 South America Dutasteride Drug Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Dutasteride Drug Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Dutasteride Drug Sales Value Share by Country, 2025 VS 2032
7 Dutasteride Drug Country-level Sales and Value Analysis
  1. 7.1 Global Dutasteride Drug Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Dutasteride Drug Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Dutasteride Drug Sales by Country (2021-2032)
  4. 7.3.1 Global Dutasteride Drug Sales by Country (2021-2026)
  5. 7.3.2 Global Dutasteride Drug Sales by Country (2027-2032)
  6. 7.4 Global Dutasteride Drug Sales Value by Country (2021-2032)
  7. 7.4.1 Global Dutasteride Drug Sales Value by Country (2021-2026)
  8. 7.4.2 Global Dutasteride Drug Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Dutasteride Drug Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Dutasteride Drug Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Dutasteride Drug Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Dutasteride Drug Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Dutasteride Drug Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Dutasteride Drug Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Dutasteride Drug Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Dutasteride Drug Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Dutasteride Drug Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Dutasteride Drug Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Dutasteride Drug Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Dutasteride Drug Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Dutasteride Drug Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Dutasteride Drug Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Dutasteride Drug Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Dutasteride Drug Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Dutasteride Drug Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Dutasteride Drug Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Dutasteride Drug Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Dutasteride Drug Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Dutasteride Drug Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Dutasteride Drug Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Dutasteride Drug Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Dutasteride Drug Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Dutasteride Drug Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Dutasteride Drug Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Dutasteride Drug Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Dutasteride Drug Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Dutasteride Drug Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Dutasteride Drug Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Dutasteride Drug Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Dutasteride Drug Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Dutasteride Drug Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Dutasteride Drug Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Dutasteride Drug Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Dutasteride Drug Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Dutasteride Drug Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Dutasteride Drug Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Dutasteride Drug Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Dutasteride Drug Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Dutasteride Drug Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Dutasteride Drug Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Dutasteride Drug Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Dutasteride Drug Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Dutasteride Drug Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Dutasteride Drug Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Dutasteride Drug Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Dutasteride Drug Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Dutasteride Drug Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Dutasteride Drug Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Dutasteride Drug Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Dutasteride Drug Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Dutasteride Drug Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Dutasteride Drug Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Dutasteride Drug Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Dutasteride Drug Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Dutasteride Drug Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Dutasteride Drug Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Dutasteride Drug Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Dutasteride Drug Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Dutasteride Drug Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Dutasteride Drug Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Dutasteride Drug Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Dutasteride Drug Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Dutasteride Drug Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Dutasteride Drug Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Dutasteride Drug Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Dutasteride Drug Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Dutasteride Drug Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Dutasteride Drug Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Dutasteride Drug Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Dutasteride Drug Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Dutasteride Drug Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Dutasteride Drug Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Dutasteride Drug Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Dutasteride Drug Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Dutasteride Drug Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Dutasteride Drug Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Dutasteride Drug Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Dutasteride Drug Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Dutasteride Drug Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Dutasteride Drug Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Dutasteride Drug Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Dutasteride Drug Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 GSK
  2. 8.1.1 GSK Company Information
  3. 8.1.2 GSK Business Overview
  4. 8.1.3 GSK Dutasteride Drug Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 GSK Dutasteride Drug Product Portfolio
  6. 8.1.5 GSK Recent Developments
  7. 8.2 Acella Pharmaceuticals
  8. 8.2.1 Acella Pharmaceuticals Company Information
  9. 8.2.2 Acella Pharmaceuticals Business Overview
  10. 8.2.3 Acella Pharmaceuticals Dutasteride Drug Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Acella Pharmaceuticals Dutasteride Drug Product Portfolio
  12. 8.2.5 Acella Pharmaceuticals Recent Developments
  13. 8.3 Amneal Pharmaceuticals
  14. 8.3.1 Amneal Pharmaceuticals Company Information
  15. 8.3.2 Amneal Pharmaceuticals Business Overview
  16. 8.3.3 Amneal Pharmaceuticals Dutasteride Drug Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Amneal Pharmaceuticals Dutasteride Drug Product Portfolio
  18. 8.3.5 Amneal Pharmaceuticals Recent Developments
  19. 8.4 Ascent Pharmaceuticals
  20. 8.4.1 Ascent Pharmaceuticals Company Information
  21. 8.4.2 Ascent Pharmaceuticals Business Overview
  22. 8.4.3 Ascent Pharmaceuticals Dutasteride Drug Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Ascent Pharmaceuticals Dutasteride Drug Product Portfolio
  24. 8.4.5 Ascent Pharmaceuticals Recent Developments
  25. 8.5 Aurobindo Pharma
  26. 8.5.1 Aurobindo Pharma Company Information
  27. 8.5.2 Aurobindo Pharma Business Overview
  28. 8.5.3 Aurobindo Pharma Dutasteride Drug Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Aurobindo Pharma Dutasteride Drug Product Portfolio
  30. 8.5.5 Aurobindo Pharma Recent Developments
  31. 8.6 Barr Pharmaceuticals
  32. 8.6.1 Barr Pharmaceuticals Company Information
  33. 8.6.2 Barr Pharmaceuticals Business Overview
  34. 8.6.3 Barr Pharmaceuticals Dutasteride Drug Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Barr Pharmaceuticals Dutasteride Drug Product Portfolio
  36. 8.6.5 Barr Pharmaceuticals Recent Developments
  37. 8.7 Chartwell
  38. 8.7.1 Chartwell Company Information
  39. 8.7.2 Chartwell Business Overview
  40. 8.7.3 Chartwell Dutasteride Drug Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Chartwell Dutasteride Drug Product Portfolio
  42. 8.7.5 Chartwell Recent Developments
  43. 8.8 Endo
  44. 8.8.1 Endo Company Information
  45. 8.8.2 Endo Business Overview
  46. 8.8.3 Endo Dutasteride Drug Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Endo Dutasteride Drug Product Portfolio
  48. 8.8.5 Endo Recent Developments
  49. 8.9 Strides Pharma
  50. 8.9.1 Strides Pharma Company Information
  51. 8.9.2 Strides Pharma Business Overview
  52. 8.9.3 Strides Pharma Dutasteride Drug Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Strides Pharma Dutasteride Drug Product Portfolio
  54. 8.9.5 Strides Pharma Recent Developments
  55. 8.10 Waylis Therapeutics
  56. 8.10.1 Waylis Therapeutics Company Information
  57. 8.10.2 Waylis Therapeutics Business Overview
  58. 8.10.3 Waylis Therapeutics Dutasteride Drug Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Waylis Therapeutics Dutasteride Drug Product Portfolio
  60. 8.10.5 Waylis Therapeutics Recent Developments
  61. 8.11 Zydus
  62. 8.11.1 Zydus Company Information
  63. 8.11.2 Zydus Business Overview
  64. 8.11.3 Zydus Dutasteride Drug Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Zydus Dutasteride Drug Product Portfolio
  66. 8.11.5 Zydus Recent Developments
  67. 8.12 Chengdu Suncadia Medicine
  68. 8.12.1 Chengdu Suncadia Medicine Company Information
  69. 8.12.2 Chengdu Suncadia Medicine Business Overview
  70. 8.12.3 Chengdu Suncadia Medicine Dutasteride Drug Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Chengdu Suncadia Medicine Dutasteride Drug Product Portfolio
  72. 8.12.5 Chengdu Suncadia Medicine Recent Developments
  73. 8.13 Jiangsu Wangao Pharmaceutical
  74. 8.13.1 Jiangsu Wangao Pharmaceutical Company Information
  75. 8.13.2 Jiangsu Wangao Pharmaceutical Business Overview
  76. 8.13.3 Jiangsu Wangao Pharmaceutical Dutasteride Drug Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Jiangsu Wangao Pharmaceutical Dutasteride Drug Product Portfolio
  78. 8.13.5 Jiangsu Wangao Pharmaceutical Recent Developments
  79. 8.14 Qilu Pharmaceutical
  80. 8.14.1 Qilu Pharmaceutical Company Information
  81. 8.14.2 Qilu Pharmaceutical Business Overview
  82. 8.14.3 Qilu Pharmaceutical Dutasteride Drug Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Qilu Pharmaceutical Dutasteride Drug Product Portfolio
  84. 8.14.5 Qilu Pharmaceutical Recent Developments
  85. 8.15 Humanwell Puracap
  86. 8.15.1 Humanwell Puracap Company Information
  87. 8.15.2 Humanwell Puracap Business Overview
  88. 8.15.3 Humanwell Puracap Dutasteride Drug Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Humanwell Puracap Dutasteride Drug Product Portfolio
  90. 8.15.5 Humanwell Puracap Recent Developments
  91. 8.16 Sichuan Gowell Pharmaceutical
  92. 8.16.1 Sichuan Gowell Pharmaceutical Company Information
  93. 8.16.2 Sichuan Gowell Pharmaceutical Business Overview
  94. 8.16.3 Sichuan Gowell Pharmaceutical Dutasteride Drug Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Sichuan Gowell Pharmaceutical Dutasteride Drug Product Portfolio
  96. 8.16.5 Sichuan Gowell Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Dutasteride Drug Value Chain Analysis
  2. 9.1.1 Dutasteride Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Dutasteride Drug Sales Mode & Process
  6. 9.2 Dutasteride Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Dutasteride Drug Distributors
  9. 9.2.3 Dutasteride Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst